Menu

日本NIPRO高钙片(NIPRO)各版本价格表

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Japanese NIPRO high calcium tablets (NIPRO) are calcium supplement preparations with calcium aspartate as the core ingredient. It is developed and produced by Japan Towa Pharmaceutical Co., Ltd. It is mainly used to improve the calcium needs of hypocalcemia, osteoporosis and special groups.

Price list of various versions of Japanese NIPRO high calcium tablets (NIPRO)

Currently, Japanese NIPRO high calcium tablets have not been officially launched in mainland China, nor have they been included in the medical insurance catalog. They need to be purchased through compliance channels.

Specifications and Prices

The specifications of the original drug produced by Nippon Shinyaku Co., Ltd. are 200mg*100 capsules/box, and the price is about US$20. Japan's NIPRO high-calcium tablets have not yet been authorized to produce generic drugs. All products circulating on the market are Japanese original versions. The price difference is mainly due to packaging specifications and transportation costs.

How to take it

The recommended daily dose for adults is 1.2 grams, taken in 2-3 times with meals, and swallowed whole with warm water. Children or the elderly need to adjust the dosage according to the doctor's advice. For example, the elderly can reduce it to 0.8 grams per day.

The tablets need to be taken out of the PTP aluminum-plastic plate. Mistaken swallowing of the packaging may cause esophageal damage. If you miss a dose, you do not need to take a double dose, just continue taking the medicine as originally planned.

Precautions for Japanese NIPRO High Calcium Tablets (NIPRO)

In order to ensure that the risk of side effects is reduced as much as possible, users need to pay attention to the following matters.

Drug interaction management

Combined use with cardiac glycosides such as digoxin may increase the risk of arrhythmia. It should be taken at least 2 hours apart from tetracycline antibiotics or fluoroquinolones to avoid the formation of compounds that are difficult to absorb. If vitamin D supplements are used at the same time, blood calcium levels need to be tested every 3 months to prevent excessive concentrations.

Long-term medication monitoring requirements

When taking the drug continuously for more than 3 months, it is recommended to conduct blood calcium, urinary calcium and renal function tests every six months. The elderly or those with mildly impaired renal function need to shorten the monitoring period to prevent stones or electrolyte disorders.

Tablets should be stored in a cool, dry place away from high temperatures or humid environments. After opening, it should be kept sealed and used within 36 months of validity. If you find that the tablets are discolored, broken, or clumped due to moisture, please stop using them immediately.

Daily care for tetany patients

Tetany is often caused by hypocalcemia. In addition to standard medication, lifestyle adjustments can significantly improve symptoms.

Dietary calcium supplement strategy

Daily intake of calcium-rich foods, such as milk, cheese, dark green vegetables and soy products. It is recommended that adults’ daily calcium intake should not be less than 1,000 mg, and they should also supplement with appropriate amounts of vitamin D to promote calcium absorption. Avoid drinking excessive amounts of coffee or alcohol to avoid accelerating calcium loss.

Moderate exercise and protection

Regular low-intensity exercise, such as walking or yoga, can enhance bone health. When tetany occurs, you need to stay calm and slowly stretch the twitching area to avoid muscle strain caused by sudden force. Pay attention to keeping your limbs warm in winter to reduce convulsions induced by cold stimulation.

Patients need to record the frequency, duration and triggers of convulsions, and provide detailed data for the doctor's reference during follow-up visits. It is recommended to review blood calcium levels every 3 months and adjust the dose of NIPRO high calcium tablets or combined treatment plan in a timely manner.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。